Baylor College of Medicine / Texas Children's Hospital
Houston, Texas, 77030, United States
NCT Number: NCT01698840
Transitional formulas (22 kcal/oz) are recommended for infants less than 35 weeks gestation at birth. However, few data are available related to follow-up of infants receiving these formulas who were 28-34 weeks gestation at birth.
Primary hypothesis: Provision of supplemental vitamin D to a transitional formula will lead to higher serum 25-hydroxyvitamin D (25-OHD) levels and no infant with a serum 25-OHD less than 20 ng/mL when assessed at approximately 52 weeks post-menstrual age (PMA).
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Last 7 days of hospitalization and at 52 weeks post-menstrual age (PMA)
Time frame: Last 7 days of hospitalization and at 52 weeks PMA
Baylor College of Medicine
Other
An Evaluation of the Effects of Two Levels of Vitamin D in Infants Fed Preterm or Transitional Formula on Serum 25-Hydroxyvitamin D and Bone Status in Preterm Infants: A Double-Blind, Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07604818
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lyon, Rhone, France
View Trial DetailsNCT02943746
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Houston, Texas, United States
View Trial DetailsNCT07137741
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Guli, Zhejiang, China
View Trial DetailsNCT04555590
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Chicago, Illinois, United States
View Trial Details